ARRDC3 and breast cancer: It is possible that reversal of EMT phenotypes is linked to sensitization of mesenchymal subtype of TNBC cells to DNA damaging agents such as 5-FU whereas non-mesenchymal breast cancer cells are less susceptible by increasing ARRDC3 or miR-200b expression.